Synairgen (FRA:OMY) Beginning Cash Position : €12.43 Mil (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Synairgen Beginning Cash Position?

Synairgen's Beginning Cash Position for the quarter that ended in Jun. 2024 was €12.43 Mil.

Synairgen's quarterly Beginning Cash Position declined from Jun. 2023 (€18.56 Mil) to Dec. 2023 (€12.34 Mil) but then increased from Dec. 2023 (€12.34 Mil) to Jun. 2024 (€12.43 Mil).

Synairgen's annual Beginning Cash Position declined from Dec. 2021 (€88.24 Mil) to Dec. 2022 (€38.90 Mil) and declined from Dec. 2022 (€38.90 Mil) to Dec. 2023 (€18.49 Mil).

Synairgen Beginning Cash Position Historical Data

The historical data trend for Synairgen's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synairgen Beginning Cash Position Chart

Synairgen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

6.23

2.71

88.24

38.90

18.49

Synairgen Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Beginning Cash Position	Get a 7-Day Free Trial															39.41	20.72	18.56	12.34	12.43

Synairgen Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Synairgen Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Synairgen's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Synairgen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synairgen PLC (FRA:OMY) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

SYGGF:USA OMY:Germany

Address

Southampton General Hospital, Tremona Road, Mailpoint 810, Level F, South Block, Southampton, GBR, SO16 6YD

Website

https://www.synairgen.com

Synairgen PLC is a United Kingdom-based respiratory drug discovery and development company. The company is engaged in the drug discovery and development of therapies for respiratory diseases, particularly in areas, including severe asthma, kidney fibrosis, cardiac fibrosis, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis. The company's Programmes include SNG001, SG016, SG018, and others.

Synairgen Headlines

No Headlines